Type 2 diabetes
Type 2 diabetes (T2D) is a progressive chronic metabolic disorder characterised by insulin deficiency and dysregulation of carbohydrate, lipid and protein metabolism. Both insulin resistance and insufficient insulin production are necessary for T2D to develop. Chronic hyperglycaemia, when combined with other metabolic abnormalities in people with T2D, can damage various organ systems, leading to the development of disabling and life-threatening health complications.
Long-term complications in T2D
Watch Professor Caroline Apovian discuss the burden and long-term complications of T2D in the following video.
Impact of T2D on long-term complications, mortality and burden
The impact of T2D on patients, healthcare systems, economies, and society is tremendous. Please sign in or register for a free account with Medthority to learn more.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
T2D treatment
Treatment options for T2D
The foundation of treatment for type 2 diabetes (T2D) is dietary adjustment and increased physical activity to facilitate weight loss, which have been demonstrated in clinical trials to be more beneficial than medication at preventing diabetes28.
With all of the latest development in T2D management, there are a variety of strategies to keep up with. To learn more about treatment options and sequencing for T2D, please sign in or register for a free account with Medthority.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
of interest
are looking at
saved
next event
This activity is supported by an educational grant from Eli Lilly and Company, this content has been developed by IMR International (Australia) independently of the sponsor Eli Lilly, who have had no editorial input into the content. IMR International (Australia) received unrestricted educational funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.